Hybrigenics Investors
Hybrigenics offers a bioinformatics platforms to identify, validate, and inhibit protein interactions to develop therapeutics for cancer.
Headquarters:
Paris, Ile-de-France, France
Industry:
Advanced and Next Generation Therapies (Various)
Investor Type:
Healthcare Company
Technology:
Advanced Longevity (R&D)
Founded Date:
1998